Exact Sciences
EXAS
#1717
Rank
NZ$16.75 B
Marketcap
$90.54
Share price
0.70%
Change (1 day)
-15.85%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.71. In 2022 the company made an earnings per share (EPS) of -$6.04 a decrease over its 2021 EPS that were of -$5.90.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.54-57.97%
2022-$6.042.31%
2021-$5.90-37.09%
2020-$9.38674.65%
2019-$1.21-50.69%
2018-$2.4644%
2017-$1.71-39.39%
2016-$2.82-2.94%
2015-$2.9037.1%
2014-$2.1279.71%
2013-$1.18-21.59%
2012-$1.5062.96%
2011-$0.9292.86%
2010-$0.48-3.45%
2009-$0.49-19.44%
2008-$0.61-18.18%
2007-$0.75-10.2%
2006-$0.84-10.91%
2005-$0.94-24.66%
2004-$1.25-51.33%
2003-$2.56-7.41%
2002-$2.7611.72%
2001-$2.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.19 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.58-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.68-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$86.84 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.43-300.57%๐Ÿ‡ซ๐Ÿ‡ท France